Contact this trialFirst, we need to learn more about you.
CDK4/6 Inhibitor
Biomarker-Driven Therapy for Breast Cancer
Recruiting1 award9 criteria
Saint Louis, Missouri
This trial will assess if measuring and acting on a biomarker (TKa) can help extend the progression-free survival of HR+ HER2- metastatic breast cancer patients on CDK4/6i and endocrine therapy.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service